Short Interest in Reckitt Benckiser Group plc (OTCMKTS:RBGLY) Decreases By 98.7%

Reckitt Benckiser Group plc (OTCMKTS:RBGLY) was the target of a large decline in short interest in March. As of March 15th, there was short interest totalling 1,800 shares, a decline of 98.7% from the February 29th total of 141,600 shares. Based on an average trading volume of 3,144,000 shares, the days-to-cover ratio is presently 0.0 days.

Reckitt Benckiser Group Stock Up 2.0 %

RBGLY traded up $0.22 during trading on Thursday, hitting $11.37. The company had a trading volume of 958,729 shares, compared to its average volume of 940,548. The firm’s 50-day moving average price is $13.56 and its 200 day moving average price is $13.76. The company has a current ratio of 0.54, a quick ratio of 0.36 and a debt-to-equity ratio of 0.57. Reckitt Benckiser Group has a one year low of $10.66 and a one year high of $16.60.

Reckitt Benckiser Group Increases Dividend

The company also recently announced a dividend, which will be paid on Monday, June 3rd. Investors of record on Friday, April 12th will be given a $0.2701 dividend. The ex-dividend date is Thursday, April 11th. This is a positive change from Reckitt Benckiser Group’s previous dividend of $0.18.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on RBGLY. Sanford C. Bernstein upgraded Reckitt Benckiser Group from a “market perform” rating to an “outperform” rating in a report on Monday, December 11th. BNP Paribas upgraded shares of Reckitt Benckiser Group from an “underperform” rating to a “neutral” rating in a research report on Tuesday, January 9th. Finally, Jefferies Financial Group downgraded shares of Reckitt Benckiser Group from a “hold” rating to an “underperform” rating in a research note on Monday, December 11th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat, Reckitt Benckiser Group has a consensus rating of “Hold” and a consensus price target of $6,978.00.

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; vaginal care routine products; sore throat medications; and hair removal products under the Clearasil, Dettol, Durex, Gaviscon, Nurofen, Mucinex, Queen V, Strepsils, and Veet brands.